Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Here's What This Label Expansion Could Mean for Eli Lilly Investors

TheMotleyFool

0 0

Here's What This Label Expansion Could Mean for Eli Lilly Investors

Jardiance, a medication well-known for treatment of type 2 diabetes, now has another importance use. This past month, Eli Lilly (NYSE: LLY) and its German partner Boehringer Ingelheim announced that the U.S. Food and Drug Administration (FDA) had approved it for reducing the risk of hospitalization and death from systolic heart failure.

This could be good news for both patients and investors. Let's examine the data that led the FDA to reach this decision, what kind of revenue it could translate into for Jardiance, and what it means for Eli Lilly overall.

Image source: Getty Images.

Source Fool.com

Like: 0

LLY

Share